Martin Auster
Stock Analyst at Raymond James
(4.56)
# 967
Out of 4,453 analysts
214
Total ratings
51.9%
Success rate
15.9%
Average return
Main Sectors:
Stocks Rated by Martin Auster
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBIO iBio, Inc. | Initiated Coverage: Buy | $5 | $1.59 | +214.47% | 1 | Jun 8, 2026 | |
| SEPN Septerna | Maintained: Buy | $38 → $53 | $34.54 | +53.45% | 2 | Jun 8, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $46 → $66 | $41.69 | +58.31% | 4 | Jun 1, 2026 | |
| EQ Equillium | Maintained: Buy | $6 → $7 | $2.95 | +137.29% | 2 | May 28, 2026 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $76 → $81 | $31.03 | +161.04% | 2 | May 26, 2026 | |
| BBIO BridgeBio Pharma | Downgraded: Hold | n/a | $69.69 | - | 4 | May 26, 2026 | |
| SYRE Spyre Therapeutics | Initiated Coverage: Buy | $80 | $88.67 | -9.78% | 1 | Apr 10, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $53 → $60 | $53.79 | +11.54% | 5 | Mar 30, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $48 → $56 | $27.02 | +107.25% | 2 | Mar 25, 2026 | |
| EVMN Evommune | Reiterated: Buy | $40 | $24.13 | +65.77% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $5.75 | +352.17% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $117 | $70.16 | +66.76% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $10.34 | +170.79% | 1 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $271 | $261.58 | +3.60% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $35 | $20.61 | +69.82% | 3 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 → $424 | $293.17 | +44.63% | 2 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $80.80 | - | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $6 | $52.77 | n/a | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $102 → $100 | $57.35 | n/a | 14 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $3.61 | n/a | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $8 | $8.86 | n/a | 4 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $12 | $22.57 | n/a | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 → $58 | $30.40 | n/a | 6 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $156 → $72 | $16.02 | n/a | 23 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $169 → $196 | $543.39 | n/a | 17 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $98 | $1.79 | n/a | 5 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $99 | $29.25 | n/a | 15 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $104.47 | n/a | 17 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $54 | $84.51 | n/a | 12 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $76 → $78 | $49.10 | n/a | 5 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $45 | $3.15 | n/a | 11 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $12 | $3.84 | n/a | 9 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $24 | $16.03 | n/a | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $43 | $10.36 | n/a | 4 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $495.00 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $14 | $0.9761 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $3.17 | n/a | 4 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $59.68 | n/a | 8 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $4 | $0.0001 | n/a | 3 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.894 | n/a | 1 | Jan 18, 2018 |
iBio, Inc.
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.59
Upside: +214.47%
Septerna
Jun 8, 2026
Maintained: Buy
Price Target: $38 → $53
Current: $34.54
Upside: +53.45%
Edgewise Therapeutics
Jun 1, 2026
Reiterated: Buy
Price Target: $46 → $66
Current: $41.69
Upside: +58.31%
Equillium
May 28, 2026
Maintained: Buy
Price Target: $6 → $7
Current: $2.95
Upside: +137.29%
Tectonic Therapeutic
May 26, 2026
Maintained: Buy
Price Target: $76 → $81
Current: $31.03
Upside: +161.04%
BridgeBio Pharma
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $69.69
Upside: -
Spyre Therapeutics
Apr 10, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $88.67
Upside: -9.78%
Scholar Rock Holding
Mar 30, 2026
Reiterated: Buy
Price Target: $53 → $60
Current: $53.79
Upside: +11.54%
Maze Therapeutics
Mar 25, 2026
Reiterated: Buy
Price Target: $48 → $56
Current: $27.02
Upside: +107.25%
Evommune
Jan 26, 2026
Reiterated: Buy
Price Target: $40
Current: $24.13
Upside: +65.77%
Jan 13, 2026
Reiterated: Buy
Price Target: $21 → $26
Current: $5.75
Upside: +352.17%
Jan 13, 2026
Reiterated: Buy
Price Target: $108 → $117
Current: $70.16
Upside: +66.76%
Dec 11, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $10.34
Upside: +170.79%
Oct 17, 2025
Initiated Coverage: Buy
Price Target: $271
Current: $261.58
Upside: +3.60%
Aug 25, 2025
Maintained: Buy
Price Target: $31 → $35
Current: $20.61
Upside: +69.82%
Aug 1, 2025
Initiated Coverage: Buy
Price Target: $55 → $424
Current: $293.17
Upside: +44.63%
Jul 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $80.80
Upside: -
Nov 16, 2021
Maintained: Buy
Price Target: $26 → $6
Current: $52.77
Upside: n/a
Oct 28, 2021
Maintained: Buy
Price Target: $102 → $100
Current: $57.35
Upside: n/a
Mar 22, 2021
Initiated Coverage: Buy
Price Target: $26
Current: $3.61
Upside: n/a
Mar 16, 2021
Maintained: Hold
Price Target: $7 → $8
Current: $8.86
Upside: n/a
Mar 16, 2021
Maintained: Buy
Price Target: $29 → $12
Current: $22.57
Upside: n/a
Mar 10, 2021
Maintained: Buy
Price Target: $49 → $58
Current: $30.40
Upside: n/a
Mar 2, 2021
Maintained: Hold
Price Target: $156 → $72
Current: $16.02
Upside: n/a
Feb 22, 2021
Maintained: Buy
Price Target: $169 → $196
Current: $543.39
Upside: n/a
Feb 11, 2021
Maintained: Buy
Price Target: $62 → $98
Current: $1.79
Upside: n/a
Jan 25, 2021
Maintained: Hold
Price Target: $64 → $99
Current: $29.25
Upside: n/a
Jan 19, 2021
Reiterated: Buy
Price Target: $50 → $60
Current: $104.47
Upside: n/a
Jan 11, 2021
Maintained: Hold
Price Target: $53 → $54
Current: $84.51
Upside: n/a
Nov 20, 2020
Maintained: Buy
Price Target: $76 → $78
Current: $49.10
Upside: n/a
Nov 10, 2020
Upgraded: Buy
Price Target: $45
Current: $3.15
Upside: n/a
Nov 6, 2020
Maintained: Hold
Price Target: $11 → $12
Current: $3.84
Upside: n/a
Nov 5, 2020
Maintained: Hold
Price Target: $21 → $24
Current: $16.03
Upside: n/a
Oct 8, 2020
Maintained: Buy
Price Target: $27 → $43
Current: $10.36
Upside: n/a
Sep 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $495.00
Upside: n/a
Sep 15, 2020
Maintained: Sell
Price Target: $14
Current: $0.9761
Upside: n/a
Aug 3, 2020
Maintained: Hold
Price Target: $5
Current: $3.17
Upside: n/a
Jul 7, 2020
Maintained: Hold
Price Target: $16
Current: $59.68
Upside: n/a
Nov 7, 2019
Downgraded: Hold
Price Target: $16 → $4
Current: $0.0001
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $0.894
Upside: n/a